{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T04:53:17Z","timestamp":1790398397404,"version":"4.1.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004097","name":"Fondation ARC pour la recherche sur le cancer","doi-asserted-by":"publisher","award":["PDF20161205256"],"award-info":[{"award-number":["PDF20161205256"]}],"id":[{"id":"10.13039\/501100004097","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thegreenjournal.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.radonc.2018.09.017","type":"journal-article","created":{"date-parts":[[2018,10,10]],"date-time":"2018-10-10T00:32:34Z","timestamp":1539131554000},"page":"150-159","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Volume effects of radiotherapy on the risk of second primary cancers: A systematic review of clinical and epidemiological studies"],"prefix":"10.1016","volume":"131","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1555-8627","authenticated-orcid":false,"given":"Neige","family":"Journy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Im\u00e8ne","family":"Mansouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1895-8415","authenticated-orcid":false,"given":"Rodrigue S.","family":"Allodji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Demoor-Goldschmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debiche","family":"Ghazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Haddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole","family":"Rubino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Veres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wael Salem","family":"Zrafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahima","family":"Diallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florent","family":"De Vathaire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2018.09.017_b0005","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S1470-2045(11)70061-4","article-title":"Proportion of second cancers attributable to radiotherapy treatment in adults: a cohort study in the US SEER cancer registries","volume":"12","author":"Berrington de Gonzalez","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2018.09.017_b0010","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1093\/jnci\/djm201","article-title":"Second cancers among 104,760 survivors of cervical cancer: evaluation of long-term risk","volume":"99","author":"Chaturvedi","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.radonc.2018.09.017_b0015","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1200\/JCO.2006.09.0936","article-title":"Long-term solid cancer risk among 5-year survivors of Hodgkin's lymphoma","volume":"25","author":"Hodgson","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2018.09.017_b0020","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1200\/JCO.2008.21.1920","article-title":"Second neoplasms in survivors of childhood cancer: findings from the Childhood Cancer Survivor Study cohort","volume":"27","author":"Meadows","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2018.09.017_b0025","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1093\/jnci\/djp104","article-title":"Lifelong cancer incidence in 47,697 patients treated for childhood cancer in the Nordic countries","volume":"101","author":"Olsen","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.radonc.2018.09.017_b0030","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1093\/jnci\/93.8.618","article-title":"Second malignant neoplasms in five-year survivors of childhood cancer: childhood cancer survivor study","volume":"93","author":"Neglia","year":"2001","journal-title":"J Natl Cancer Inst."},{"key":"10.1016\/j.radonc.2018.09.017_b0035","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1200\/JCO.2013.54.4601","article-title":"Breast cancer after chest radiation therapy for childhood cancer","volume":"32","author":"Moskowitz","year":"2014","journal-title":"J Clin Oncology"},{"key":"10.1016\/j.radonc.2018.09.017_b0040","unstructured":"Curtis R, Freedman D, Ron E, Ries LAG, Hacker DG, Edwards BK, et al. New malignancies among cancer survivors: SEER cancer registries, 1973-2000. NIH Publ. No. 05-5302. Bethesda, MD, USA: National Cancer Institute; 2006."},{"key":"10.1016\/j.radonc.2018.09.017_b0045","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1038\/sj.bjc.6690300","article-title":"Second malignant neoplasms after a first cancer in childhood: temporal pattern of risk according to type of treatment","volume":"79","author":"de Vathaire","year":"1999","journal-title":"Br J Cancer"},{"key":"10.1016\/j.radonc.2018.09.017_b0050","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0360-3016(03)00073-7","article-title":"Radiation-induced second cancers: the impact of 3D-CRT and IMRT","volume":"56","author":"Hall","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2018.09.017_b0055","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1097\/01.HP.0000326342.47348.06","article-title":"Dose to normal tissues outside the radiation therapy patient's treated volume: a review of different radiation therapy techniques","volume":"95","author":"Purdy","year":"2008","journal-title":"Health Phys"},{"key":"10.1016\/j.radonc.2018.09.017_b0060","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1001\/jamaoncol.2016.1368","article-title":"Second primary cancers after intensity-modulated vs 3-dimensional conformal radiation therapy for prostate cancer","volume":"2","author":"Journy","year":"2016","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.radonc.2018.09.017_b0065","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ijrobp.2013.04.030","article-title":"Incidence of second malignancies among patients treated with proton versus photon radiation","volume":"87","author":"Chung","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2018.09.017_b0070","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1002\/cam4.743","article-title":"Proton beam therapy for pediatric malignancies: a retrospective observational multicenter study in Japan","volume":"5","author":"Mizumoto","year":"2016","journal-title":"Cancer Med"},{"key":"10.1016\/j.radonc.2018.09.017_b0075","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/1748-717X-8-172","article-title":"ESTRO BPgotG. Second primary cancers after radiation for prostate cancer: a review of data from planning studies","volume":"8","author":"Murray","year":"2013","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2018.09.017_b0080","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s13014-016-0723-6","article-title":"Estimation of second cancer risk after radiotherapy for rectal cancer: comparison of 3D conformal radiotherapy and volumetric modulated arc therapy using different high dose fractionation schemes","volume":"11","author":"Zwahlen","year":"2016","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2018.09.017_b0085","doi-asserted-by":"crossref","first-page":"806","DOI":"10.3109\/0284186X.2011.582514","article-title":"Radiobiological risk estimates of adverse events and secondary cancer for proton and photon radiation therapy of pediatric medulloblastoma","volume":"50","author":"Brodin","year":"2011","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2018.09.017_b0090","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ijrobp.2015.02.030","article-title":"Optimized volumetric modulated arc therapy versus 3D-CRT for early stage mediastinal Hodgkin lymphoma without axillary involvement: a comparison of second cancers and heart disease risk","volume":"92","author":"Filippi","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2018.09.017_b0095","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/02841860802657227","volume":"48","author":"Johansen","year":"2009","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2018.09.017_b0100","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/j.ijrobp.2004.12.040","article-title":"Estimation of radiation-induced cancer from three-dimensional dose distributions: Concept of organ equivalent dose","volume":"61","author":"Schneider","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2018.09.017_b0105","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1742-4682-8-27","article-title":"Site-specific dose-response relationships for cancer induction from the combined Japanese A-bomb and Hodgkin cohorts for doses relevant to radiotherapy","volume":"8","author":"Schneider","year":"2011","journal-title":"Theor Biol Med Model"},{"key":"10.1016\/j.radonc.2018.09.017_b0110","series-title":"Holland-Frei cancer medicine","article-title":"Principal cellular and tissue effects of radiation","author":"Little","year":"2003"},{"key":"10.1016\/j.radonc.2018.09.017_b0115","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ejmp.2017.02.013","article-title":"Photons \u2013 radiobiological issues related to the risk of second malignancies","volume":"42","author":"Marcu","year":"2017","journal-title":"Phys Med"},{"key":"10.1016\/j.radonc.2018.09.017_b0120","series-title":"Basic clinical radiobiology","first-page":"191","author":"Dorr","year":"2009"},{"key":"10.1016\/j.radonc.2018.09.017_b0125","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/S1470-2045(09)70082-8","article-title":"Systemic effects of local radiotherapy","volume":"10","author":"Formenti","year":"2009","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.radonc.2018.09.017_b0130","unstructured":"ICRU. ICRU Report 83: Prescribing, Recording, and Reporting Photon-Beam Intensity-Modulated Radiation Therapy (IMRT). Bethesda, MD, USA: International Commission on Radiation Units and Measurements; 2010. p. 1\u2013106."},{"key":"10.1016\/j.radonc.2018.09.017_b0135","doi-asserted-by":"crossref","first-page":"W64","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"151","author":"Moher","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.radonc.2018.09.017_b0140","unstructured":"UNSCEAR. Principles and criteria for ensuring the quality of the Committee's reviews of epidemiological studies of radiation exposure. In: Sources, Effects and Risks of Ionizing Radiation, United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR) 2017 Report2018."},{"key":"10.1016\/j.radonc.2018.09.017_b0145","first-page":"CD003187","article-title":"Chemotherapy, radiotherapy and combined modality for Hodgkin's disease, with emphasis on second cancer risk","author":"Franklin","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.radonc.2018.09.017_b0150","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.clon.2004.07.004","article-title":"Long-term results of a randomised trial of involved field radiotherapy vs extended field radiotherapy in stage I and II Hodgkin lymphoma","volume":"17","author":"Hoskin","year":"2005","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.radonc.2018.09.017_b0155","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1056\/NEJMoa064601","article-title":"Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease","volume":"357","author":"Ferme","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2018.09.017_b0160","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0360-3016(94)90222-4","article-title":"Second solid tumors and leukemia after treatment for Hodgkin's disease: an analysis of 1121 patients from a single institution","volume":"29","author":"Biti","year":"1994","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2018.09.017_b0165","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0360-3016(96)00498-1","article-title":"Increased risk of breast cancer in splenectomized patients undergoing radiation therapy for Hodgkin's disease","volume":"37","author":"Chung","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2018.09.017_b0170","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0360-3016(00)00647-7","article-title":"The need for long-term surveillance for patients treated with curative radiotherapy for Hodgkin's disease: University of Minnesota experience","volume":"48","author":"Lee","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2018.09.017_b0175","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1200\/JCO.2001.19.6.1610","article-title":"Lung cancer after Hodgkin's disease: a nested case-control study of the relation to treatment","volume":"19","author":"Swerdlow","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2018.09.017_b0180","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1182\/blood-2002-02-0634","article-title":"Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: long-term risks and risk factors","volume":"100","author":"Ng","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.radonc.2018.09.017_b0185","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1524-4741.2010.00904.x","article-title":"Breast cancer following Hodgkin's Disease: the experience of the University of Florence","volume":"16","author":"Meattini","year":"2010","journal-title":"Breast J"},{"key":"10.1016\/j.radonc.2018.09.017_b0190","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1365-2141.2012.09211.x","article-title":"Patterns of subsequent malignancies after Hodgkin lymphoma in children and adults","volume":"158","author":"Omer","year":"2012","journal-title":"Br J Haemat"},{"key":"10.1016\/j.radonc.2018.09.017_b0195","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1200\/JCO.2011.38.8835","article-title":"Breast cancer risk after supradiaphragmatic radiotherapy for Hodgkin's lymphoma in England and Wales: a National Cohort Study","volume":"30","author":"Swerdlow","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2018.09.017_b0200","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1056\/NEJMoa1505949","article-title":"Second Cancer Risk Up to 40 Years after Treatment for Hodgkin's Lymphoma","volume":"373","author":"Schaapveld","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2018.09.017_b0205","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1200\/JCO.2000.18.12.2406","article-title":"Second malignancies after treatment of early-stage breast cancer: lumpectomy and radiation therapy versus mastectomy","volume":"18","author":"Obedian","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2018.09.017_b0210","doi-asserted-by":"crossref","first-page":"768","DOI":"10.4236\/jct.2012.325096","article-title":"Region of Treatment in Radiotherapy and Second Malignancies in Breast Cancer Patients","volume":"3","author":"Zhang","year":"2012","journal-title":"J Cancer Ther"},{"key":"10.1016\/j.radonc.2018.09.017_b0215","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.ijrobp.2014.12.051","article-title":"Second malignancies after adjuvant radiation therapy for early stage breast cancer: is there increased risk with addition of regional radiation to local radiation?","volume":"91","author":"Hamilton","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2018.09.017_b0220","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1200\/JCO.2011.37.8760","article-title":"Secondary colorectal carcinoma after childhood cancer","volume":"30","author":"Nottage","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2018.09.017_b0225","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0360-3016(97)00570-1","article-title":"Is there an increased risk of second primaries following prostate irradiation?","volume":"41","author":"Movsas","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2018.09.017_b0230","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1002\/sim.4780101004","article-title":"Radiation dose and leukaemia risk: general relative risk techniques for dose-response models in a matched case-control study","volume":"10","author":"Blettner","year":"1991","journal-title":"Stat Med"},{"key":"10.1016\/j.radonc.2018.09.017_b0235","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1016\/j.ijrobp.2009.09.032","article-title":"Role of radiation dose in the risk of secondary leukemia after a solid tumor in childhood treated between 1980 and 1999","volume":"78","author":"Allard","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2018.09.017_b0240","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.ijrobp.2015.07.2270","article-title":"Risk of subsequent leukemia after a solid tumor in childhood: impact of bone marrow radiation therapy and chemotherapy","volume":"93","author":"Allodji","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2018.09.017_b0245","first-page":"381","article-title":"Risk of second bone sarcoma following childhood cancer: role of radiation therapy treatment","volume":"53","author":"Schwartz","year":"2014","journal-title":"Radiat Environ Biophys"},{"key":"10.1016\/j.radonc.2018.09.017_b0250","article-title":"Optimisation of chemotherapy and radiotherapy for untreated Hodgkin lymphoma patients with respect to second malignant neoplasms, overall and progression-free survival: individual participant data analysis","volume":"9","author":"Franklin","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.radonc.2018.09.017_b0255","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.ijrobp.2007.10.034","article-title":"Risk of a second malignant neoplasm after cancer in childhood treated with radiotherapy: correlation with the integral dose restricted to the irradiated fields","volume":"70","author":"Nguyen","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2018.09.017_b0260","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ijrobp.2012.09.001","article-title":"Second solid cancers after radiation therapy: a systematic review of the epidemiologic studies of the radiation dose-response relationship","volume":"86","author":"Berrington de Gonzalez","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2018.09.017_b0265","doi-asserted-by":"crossref","first-page":"13040","DOI":"10.1073\/pnas.0506648102","article-title":"Solid tumor risks after high doses of ionizing radiation","volume":"102","author":"Sachs","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.radonc.2018.09.017_b0270","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00411-009-0230-3","article-title":"A new view of radiation-induced cancer: integrating short- and long-term processes. Part I: approach","volume":"48","author":"Shuryak","year":"2009","journal-title":"Radiat Environ Biophys"},{"key":"10.1016\/j.radonc.2018.09.017_b0275","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1093\/jnci\/djj497","article-title":"Radiation-induced leukemia at doses relevant to radiation therapy: modeling mechanisms and estimating risks","volume":"98","author":"Shuryak","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.radonc.2018.09.017_b0280","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.ijrobp.2009.01.040","article-title":"Frequency distribution of second solid cancer locations in relation to the irradiated volume among 115 patients treated for childhood cancer","volume":"74","author":"Diallo","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2018.09.017_b0285","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.ijrobp.2014.08.335","article-title":"Retrospective reconstructions of active bone marrow dose-volume histograms","volume":"90","author":"Veres","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2018.09.017_b0290","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1088\/0031-9155\/60\/6\/2309","article-title":"Reconstruction of organ dose for external radiotherapy patients in retrospective epidemiologic studies","volume":"60","author":"Lee","year":"2015","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.radonc.2018.09.017_b0295","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.ijrobp.2013.03.014","article-title":"Radiation dose to the esophagus from breast cancer radiation therapy, 1943\u20131996: an international population-based study of 414 patients","volume":"86","author":"Lamart","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2018.09.017_b0300","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.ijrobp.2009.07.1754","article-title":"Use of normal tissue complication probability models in the clinic","volume":"76","author":"Marks","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2018.09.017_b0305","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.ijrobp.2014.07.008","article-title":"Functional data analysis in NTCP modeling: a new method to explore the radiation dose-volume effects","volume":"90","author":"Benadjaoud","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016781401833500X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016781401833500X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T13:40:41Z","timestamp":1565271641000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016781401833500X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":61,"alternative-id":["S016781401833500X"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2018.09.017","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Volume effects of radiotherapy on the risk of second primary cancers: A systematic review of clinical and epidemiological studies","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2018.09.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}